Healthcare Investment Banks by Company Size and Transaction Type

Choosing the right healthcare investment bank is less about brand recognition and more about fit, especially with the bankers a client works with day to day. Investment banks are purpose-built to serve different market segments, defined primarily by company size, transaction value, and buyer universe. A bank that excels in $2 billion public-company transactions is not necessarily the right advisor for a $50 million founder-owned healthcare services business, and vice versa.

Below, we break down the healthcare investment banking landscape by market segment, highlighting the types of companies each group serves and the firms that lead in each category.

Disclaimer: This analysis reflects our opinion based on publicly available information and market research. It is for informational purposes only, does not constitute investment advice, and does not guarantee outcomes. Readers should conduct their own due diligence when selecting an investment bank.

Market Segmentation Overview

Bulge Bracket Healthcare Transactions

Bulge bracket banks operate at the top of the healthcare M&A market, advising public companies and very large private equity–backed enterprises on transformational transactions. These deals often involve complex financing structures, cross-border considerations, and sophisticated capital markets execution, areas where global scale and institutional relationships are decisive advantages.

Their teams and infrastructure are built to manage multi-billion-dollar mandates from origination through close.

Goldman Sachs is one of the most prominent advisors in large-cap healthcare M&A, serving global pharmaceutical companies, medical device manufacturers, and diversified healthcare conglomerates. The firm is particularly well-suited to complex strategic transactions, large-scale acquisitions, and IPOs where access to institutional capital and global investor networks is essential. Goldman’s healthcare clients are typically public companies or sponsor-backed enterprises operating at significant scale.

Key facts:

• Founded: 1869, by Marcus Goldman
• Headquarters: New York, United States
• Employees: ~46,500
• Market capitalization: ≈ $279 billion (Dec 2025)

J.P. Morgan brings together investment banking expertise and one of the largest balance sheets in global finance, a combination that makes it a go-to advisor for healthcare companies pursuing capital-intensive or highly structured transactions. The firm is especially active in healthcare services, life sciences, and payer-related deals at the upper end of the market. Its clients typically include large corporate acquirers and private equity sponsors overseeing multi-billion-dollar assets.

Key facts:

• Headquarters: New York City, U.S.
• Global reach: Operations in 100+ countries
• CEO (JPMorgan Chase): Jamie Dimon (2025)
• Market capitalization: ≈ US $834 billion (2025)

Upper Middle Market Healthcare Companies

($200M–$1B transactions, $20–100M EBITDA)

Upper middle market healthcare banks serve scaled platforms, most commonly those backed by private equity. Transactions at this level typically involve recapitalizations, sponsor exits, or large add-on consolidations requiring coordinated institutional buyer processes and financing from third-party lenders.

Banks in this tier generally cover both healthcare services and healthcare technology, though individual firms tend to skew toward one or the other. They are well-equipped for structured processes but typically maintain minimum deal size thresholds that can screen out many smaller opportunities.

Houlihan Lokey is one of the most active advisors in upper-middle-market healthcare M&A, with a deep track record across healthcare services, life sciences, and healthcare IT. The firm is a frequent choice for private equity firms, particularly in sponsor-to-sponsor transactions.

Key facts:

• Founded: 1972
• Headquarters: Los Angeles, California, United States
• Employees: ≈2,700 (2025)
• Market capitalization: ≈$12 billion (late 2025)

William Blair is recognized for its relationship-driven advisory approach and a well-established healthcare franchise. The firm covers a broad range of healthcare transactions, including services, medtech, and healthcare technology, and typically advises large private companies or PE-backed platforms pursuing strategic or financial exits at meaningful scale.

Key facts:

• Founded: 1935
• Headquarters: Chicago, Illinois, U.S.
• Employees: ~1,900 across 20+ offices worldwide
• Client assets: About $82 billion (2025)

Cain Brothers is a healthcare-only boutique (part of KeyBank) with a long-standing reputation in healthcare services, health systems, and provider-based businesses. The firm regularly advises large nonprofit and for-profit healthcare organizations as well as private equity–backed platforms. Its expertise is most apparent in complex, institutionally scaled transactions where deep sector knowledge is a prerequisite.

Key facts:

• Founded: 1982
• Headquarters: New York City, United States
• Specialization: Healthcare investment banking and advisory
• Services: M&A advisory, capital raising, strategic consulting

TripleTree focuses on healthcare technology and services, with particular depth in software, IT services, and analytics-driven healthcare businesses.

Key facts:

• Founded: 1997
• Headquarters: Minneapolis, Minnesota, USA
• Industry focus: Healthcare technology, services, and pharma services
• Parent company: Capital One (since 2021)

Piper Sandler operates a broad healthcare investment banking practice spanning services, medtech, and healthcare IT. The firm primarily advises larger private companies and sponsor-backed platforms, with a process orientation suited to institutional buyers and transactions that require public-market-level diligence and preparation.

Key facts:

• Founded: 1895
• Headquarters: Minneapolis, Minnesota, U.S.
• Employees: ~1,800 (2025)
• Market capitalization: ≈ $6.3 billion (Dec 2025)

Lower Middle Market Healthcare Companies

($20M–$200M transactions, $2–20M EBITDA)

The lower middle market is one of the most active segments in healthcare M&A and one of the most underserved. These businesses tend to be founder-owned, regionally concentrated, and operationally complex, yet they fall below the size thresholds that attract consistent attention from larger middle-market banks. Transactions in this range typically involve sales to private equity funds, PE-backed companies, or other larger strategic buyers.

FOCUS Investment Banking’s healthcare group was built expressly to serve companies in this size range. The firm brings a full institutional M&A process to businesses that most upper middle market banks would decline based on deal size alone. With a dedicated focus on healthcare services and adjacent sectors, FOCUS delivers deep buyer market knowledge, operational context, and tailored positioning — capabilities that are especially valuable for founder-owned businesses entering a sale process for the first time.

Where larger banks prioritize scale, FOCUS prioritizes experience in a specific seller type and transaction size. Senior banker involvement, process rigor, and attentiveness to owner priorities are hallmarks of the firm’s approach. That approach has made FOCUS a trusted advisor for healthcare entrepreneurs seeking private equity or strategic partners.

Key facts:

• Founded: 1982
• Headquarters: Washington, D.C., United States
• Employees: 51–200
• Global footprint: Offices in Atlanta, Nashville, Los Angeles, Dublin, and Limerick

Small Healthcare Transactions

(Transactions under $20M, under $2M EBITDA)

Smaller healthcare transactions generally involve owner-operated practices or service businesses and attract buyers such as individual operators or local strategic acquirers. These deals do not typically require broad institutional buyer outreach or complex transaction structures.

Transworld Business Brokers runs one of the largest networks of local business brokers in the country, serving sellers across many industries including healthcare. Its model is best suited to relatively straightforward transactions involving small practices or owner-operated service businesses where a regional or individual buyer is the most likely counterparty.

Key facts:

• Founded: 1979
• Headquarters: West Palm Beach, Florida, USA
• Scale: 250+ offices and 1,000+ brokers worldwide (franchise network)
• Core services: Business sales, mergers and acquisitions, franchise sales, and consulting

If you’d like to learn more about our healthcare investment banking services, reach out here.